Abstract
A 10-year-old boy with high-risk acute lymphoblastic leukemia treated with hematopoietic stem-cell transplantation developed pulmonary aspergillosis while receiving prophylactic voriconazole. A transpleural aspirate culture revealed a pan-azole-resistant Aspergillus fumigatus. Treatment with liposomal amphotericin B resulted in complete recovery. As the frequency of azole resistance in A. fumigatus increases, invasive procedures to isolate fungi for species identification and susceptibility testing becomes even more important.
Original language | English |
---|---|
Pages (from-to) | 268-270 |
Number of pages | 3 |
Journal | The Pediatric infectious disease journal |
Volume | 30 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2011 |
Keywords
- Amphotericin B
- Antifungal Agents
- Aspergillus fumigatus
- Azoles
- Chemoprevention
- Child
- Drug Resistance, Multiple, Fungal
- Hematopoietic Stem Cell Transplantation
- Humans
- Male
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Aspergillosis
- Pyrimidines
- Treatment Outcome
- Triazoles
- Voriconazole